FEASIBILITY OF PERIOPERATIVE CHEMOTHERAPY WITH INFUSIONAL 5-FU, LEUCOVORIN AND OXALIPLATIN ± DOCETAXEL, IN ELDERLY PATIENTS WITH LOCALLY ADVANCED ESOPHAGOGASTRIC CANCER

被引：0
|
作者：
Lorenzen, Sylvie [1 ]
Pauligk, C. [2 ]
Homann, N. [3 ]
Schmalenberg, H. [4 ]
Tauchert, F. [2 ]
Jaeger, E. [2 ]
Al-Batran, S. -E. [2 ]
机构：
[1] Univ Heidelberg, Natl Ctr Tumor Dis, D-6900 Heidelberg, Germany
[2] Krankenhaus NW Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany
[3] Klinikum Wolfsburg, Dept Med 2, Wolfsburg, Germany
[4] Dept Med 2, Jena, Germany
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with or without docetaxel, in elderly patients with locally advanced esophagogastric cancer
    Pauligk, C.
    Lorenzen, S.
    Homann, N.
    Schmalenberg, H.
    Tauchert, F.
    Jaeger, E.
    Al-Batran, S-E
    [J]. ONKOLOGIE, 2012, 35 : 165 - 166
  • [2] Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
    Lorenzen, S.
    Pauligk, C.
    Homann, N.
    Schmalenberg, H.
    Jaeger, E.
    Al-Batran, S-E
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (03) : 519 - 526
  • [3] Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
    S Lorenzen
    C Pauligk
    N Homann
    H Schmalenberg
    E Jäger
    S-E Al-Batran
    [J]. British Journal of Cancer, 2013, 108 : 519 - 526
  • [4] Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
    Glatz, Torben
    Verst, Rasmus
    Kuvendjiska, Jasmina
    Bronsert, Peter
    Becker, Heiko
    Hoeppner, Jens
    Kulemann, Birte
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 14
  • [5] Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
    Sah, Birendra Kumar
    Xu, Wei
    Zhang, Benyan
    Zhang, Huan
    Yuan, Fei
    Li, Jian
    Liu, Wentao
    Yan, Chao
    Li, Chen
    Yan, Min
    Zhu, Zhenggang
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
  • [6] Feasibility of neoadjuvant chemotherapy with modified FOLFOX6 (combination chemotherapy of infusional 5-FU/l-Leucovorin and intermittent oxaliplatin) with bevacizumab in patients with locally advanced lower rectal cancer
    Kosugi, C.
    Koda, K.
    Tanaka, K.
    Miyazawa, Y.
    Shuto, K.
    Matsuo, K.
    Mori, M.
    Hirano, A.
    Endo, S.
    Hiroshima, Y.
    Sazuka, T.
    Yanagibashi, H.
    Kikuchi, Y.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 78 - 78
  • [7] Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective
    Sisic, Leila
    Crnovrsanin, Nerma
    Nienhueser, Henrik
    Jung, Jin-On
    Schiefer, Sabine
    Haag, Georg Martin
    Bruckner, Thomas
    Schneider, Martin
    Mueller-Stich, Beat P.
    Buechler, Markus W.
    Schmidt, Thomas
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [8] Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective
    Leila Sisic
    Nerma Crnovrsanin
    Henrik Nienhueser
    Jin-On Jung
    Sabine Schiefer
    Georg Martin Haag
    Thomas Bruckner
    Martin Schneider
    Beat P. Müller-Stich
    Markus W. Büchler
    Thomas Schmidt
    [J]. Langenbeck's Archives of Surgery, 408
  • [9] Phase II trial of oxaliplatin, 5-FU, and leucovorin chemotherapy for the previously treated patients with advanced gastric cancer
    Oh, S. C.
    Kim, Y.
    Kim, J.
    Choi, I.
    Sung, H.
    Seo, H.
    Shin, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
    Ducreux, M
    Mitry, E
    Ould-Kaci, M
    Boige, V
    Seitz, JF
    Bugat, R
    Breau, JL
    Bouchè, O
    Etienne, PL
    Tigaud, JM
    Morvan, F
    Cvitkovic, E
    Rougier, P
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 467 - 473
12345